Search by Drug Name or NDC

    NDC 00143-9309-01 Thiotepa 15 mg/1.5mL Details

    Thiotepa 15 mg/1.5mL

    Thiotepa is a INTRACAVITARY; INTRAVENOUS; INTRAVESICAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is THIOTEPA.

    Product Information

    NDC 00143-9309
    Product ID 0143-9309_43ac39a1-a0e0-48e9-93e2-e7e754bc6038
    Associated GPIs 21100040002105
    GCN Sequence Number 008776
    GCN Sequence Number Description thiotepa VIAL 15 MG INJECTION
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 38410
    HICL Sequence Number 003898
    HICL Sequence Number Description THIOTEPA
    Brand/Generic Generic
    Proprietary Name Thiotepa
    Proprietary Name Suffix n/a
    Non-Proprietary Name Thiotepa
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1.5mL
    Substance Name THIOTEPA
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Alkylating Activity [MoA], Alkylating Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075547
    Listing Certified Through 2024-12-31

    Package

    NDC 00143-9309-01 (00143930901)

    NDC Package Code 0143-9309-01
    Billing NDC 00143930901
    Package 1 VIAL in 1 BOX, UNIT-DOSE (0143-9309-01) / 1.5 mL in 1 VIAL
    Marketing Start Date 2001-06-01
    NDC Exclude Flag N
    Pricing Information N/A